Skip to main content
Premium Trial:

Request an Annual Quote

Institut Curie to Use Affy Arrays to Develop Cancer Diagnostics

NEW YORK, Feb. 2 (GenomeWeb News) - The Institut Curie of France will use Affymetrix microarrays in several large-scale clinical studies aimed at developing diagnostic tests for cancer, the two partners said today.

 

Institut Cure, a private cancer research center based in Paris, plans several translational medicine studies, based on its library of frozen tumor samples, which will use Affymetrix's GeneChip arrays.

 

The first two project aim to identify prognostic markers for breast cancer relapse and for metastasis of uveal melanoma, a form of eye cancer.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.